Haleon HLN
NYSE HLN
$9.90 +0.03 (+0.30%)
At close: Aug 20, 2026 · 12:51 PM UTC

Haleon (HLN) Other Non-Current Assets (2021 - 2026)

Haleon's (HLN) quarterly Other Non-Current Assets came in at $56.4 million in Q2 2026, up 13.67% on a QoQ basis from $49.6 million in Q4 2025.

Haleon (HLN) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Other Non-Current Assets data on file, last reported at $56.4 million in Q2 2026.

  • Quarterly Other Non-Current Assets changed N/A year-over-year to $56.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $56.4 million (changed N/A YoY) and the FY2025 annual result came in at $49.2 million, down 53.05% from the prior year.
  • Other Non-Current Assets climbed to $56.4 million in Q2 2026, from $49.6 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $154.8 million in Q4 2022 to a low of $49.6 million in Q4 2025.
  • A 5-year average of $100.5 million and a median of $101.9 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 1335.69% — and 2025, when it slumped 52.9%.
  • Tracing HLN's Other Non-Current Assets over 5 years: stood at $154.8 million in 2022, then dropped by 8.61% to $141.5 million in 2023, then dropped by 25.62% to $105.2 million in 2024, then tumbled by 52.9% to $49.6 million in 2025, then gained by 13.67% to $56.4 million in 2026.
  • The last three Other Non-Current Assets figures came in at $56.4 million (Q2 2026), $49.6 million (Q4 2025), and $105.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - 56.35 Mn
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 1.79 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn 384.00 Mn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn 503.80 Mn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 239.50 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn 1.06 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn 59.30 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 304.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn - 13.00 Mn
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn 62.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 56.35 Mn
Dec 31, 2025 49.57 Mn
Dec 31, 2024 105.25 Mn
Jun 30, 2024 98.45 Mn
Dec 31, 2023 141.49 Mn
Jun 30, 2023 141.40 Mn
Dec 31, 2022 154.83 Mn
Jun 30, 2022 56.67 Mn
Dec 31, 2021 10.78 Mn